These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30335850)

  • 21. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary drug-resistance is the main cause of drug-resistant tuberculosis].
    Mei J; Xue Z; Shen X; Shen GM; Gui XH; Shen M; Gao Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):75-8. PubMed ID: 16677445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant tuberculosis: treatment is empirical, for want of robust trials.
    Prescrire Int; 2014 Oct; 23(153):245-6. PubMed ID: 25964976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Rando-Segura A; Aznar ML; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil E; Eugénio ANE; Escartin C; Zacarias A; Vegue J; Katimba D; Vivas MC; Gabriel E; Marina MC; Mendioroz J; López MT; Pumarola T; Molina I; Tórtola MT
    Emerg Infect Dis; 2018 Mar; 24(3):569-572. PubMed ID: 29460748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.
    Lange C; Chesov D; Heyckendorf J; Leung CC; Udwadia Z; Dheda K
    Respirology; 2018 Jul; 23(7):656-673. PubMed ID: 29641838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Ho PL; Yam WC; Leung CC; Yew WW; Mok TY; Chan KS; Tam CM
    Hong Kong Med J; 2015 Jun; 21 Suppl 4():4-7. PubMed ID: 26157093
    [No Abstract]   [Full Text] [Related]  

  • 30. Innovations in tuberculosis diagnostics: How far are we from reaching our goal?
    Varma-Basil M; Bose M
    Indian J Med Res; 2019 Jul; 150(1):4-6. PubMed ID: 31571624
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 32. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
    Rattan A; Kalia A; Ahmad N
    Emerg Infect Dis; 1998; 4(2):195-209. PubMed ID: 9621190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
    Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

  • 37. External quality assurance of drug susceptibility testing in the southern African development community.
    Mativandlela SP; Brand J; Matlhola N; Sewpersadh M; Olorunju SA; van der Walt ML
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):425. PubMed ID: 23407237
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 39. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
    Yew WW; Lange C
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.